SciVision Biotech Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 712.99 million compared to TWD 557.35 million a year ago. Net income was TWD 177.9 million compared to TWD 141.72 million a year ago.

Basic earnings per share from continuing operations was TWD 2.66 compared to TWD 2.14 a year ago. Diluted earnings per share from continuing operations was TWD 2.41 compared to TWD 1.92 a year ago.